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Abstract 
The study aims were to investigate the cost-benefit of different strategies to treat and 
control ovine footrot. In November 2006, 162 sheep farmers responded to a survey on 
prevalence and management of lameness. Reading University’s Farm Health Planning footrot 
calculator was used to calculate costs of lameness per ewe per year (PEPY) for 116 flocks. 
Linear regression was used to model the overall cost of lameness PEPY, by management 
method. Associations between farmer satisfaction and time and money spent managing 
lameness were investigated. 
The median prevalence of lameness was 5% (inter-quartile range [IQR]: 4-10%). The overall 
cost of lameness PEPY in flocks with ≥10% lameness was £6.35 versus £3.90 for flocks with 
<5% lameness. Parenteral antibiotic treatment was associated with significantly lower overall 
cost of lameness by £0.79 PEPY. Routine foot trimming and footbathing were associated 
with significantly higher overall costs of lameness PEPY of £2.96 and £0.90 respectively.  
Farmers satisfied with time managing lameness spent significantly less time (1.46 
hours PEPY) than unsatisfied farmers (1.90 hours PEPY). Farmers satisfied with money 
spent managing lameness had significantly lower treatment (£2.94 PEPY) and overall (£5.00 
PEPY) costs than dissatisfied farmers (£5.50 and £7.60 PEPY respectively). 
If the farmers in this study adopted best practice of parenteral antibiotic treatment 
with no routine foot trimming, and minimised footbathing to treating/preventing interdigital 
dermatitis, the financial benefits would be approximately £4.65 PEPY. If these costs are 
similar on other farms the management changes would lead to significant economic benefits 
for the sheep industry. 
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Introduction 
Footrot is an infectious bacterial disease of sheep caused by Dichelobacter nodosus. 
Clinical presentation is interdigital dermatitis (ID) alone, or severe footrot (SFR) with various 
degrees of separation of hoof horn from the sensitive tissue; both conditions cause lameness. 
In England, the majority of ovine lameness is attributed to footrot (Kaler and Green, 2008; 
Winter et al., 2015). English farmers manage footrot using whole-flock strategies (quarantine, 
foot trimming, footbathing, vaccination) and individual treatments; using one or more of foot 
trimming, topical disinfectant and systemic antibiotic injection (Winter et al., 2015). 
Routine foot trimming can cause damage to sensitive tissue, which is associated with 
a higher prevalence of lameness (Winter et al., 2015). Footbathing is generally associated 
with higher prevalence of lameness (Kaler and Green, 2009; Winter et al., 2015), except 
when used to prevent ID (Winter et al., 2015) or when handling facilities are excellent and 
sheep are turned onto pasture free from sheep for at least 2 weeks (Wassink et al., 2003, 
2004). In past observational studies, vaccination was not significantly associated with 
prevalence of lameness (Wassink et al., 2004; Kaler and Green, 2009) but in a recent, 2013, 
study it was associated with a 20% reduction (Winter et al., 2015).  
Footrot is one of the top five economically important diseases of sheep globally. In 
the UK footrot costs the sheep industry £24 - £80 million1 per annum (Nieuwhof and Bishop, 
2005; Wassink et al., 2010b). Economic losses from lameness occur in ewes left untreated for 
one week (Wassink et al., 2010b). Losses arise from ewe deaths and infertility (Stewart et al., 
1984; Marshall et al., 1991; Nieuwhof et al., 2008), reduced numbers of lambs born and 
surviving, and reduced lamb growth rates (Wassink et al., 2010b).  
                                                 
1 £1 GBP = approx. €1.268 and $1.433 USD on 21st April 2016. See: Reuters, 
http://uk.reuters.com/business/currencies (accessed 21/04/2016)  
 
In 2006, 265 English farmers were asked whether they were satisfied with their 
management of lameness; 162 responded (Wassink et al., 2010a). Among ‘very satisfied’ 
farmers, the annual prevalence of lameness was ≤5%. Those farmers were significantly more 
likely to catch and treat lame sheep within 3 days and to treat sheep with footrot with 
parenteral and topical antibacterial products which leads to rapid recovery (Kaler et al., 
2010a; Kaler et al., 2012; Strobel et al., 2014); although most farmers were also 
therapeutically trimming the foot, which reduces the rate of recovery (Kaler et al., 2010a). 
Farmers dissatisfied with their management of lameness had a median lameness 
prevalence of 9.8%; dissatisfaction was associated with vaccination and routine footbathing 
(Wassink et al., 2010a). Dissatisfied farmers indicated that they were interested in changing 
their management (Wassink et al., 2010a), but also reported footbathing and vaccination as 
strategies they would like to use more. Additionally, it has been suggested anecdotally that 
individually treating lame sheep is costly in time to catch individual ewes and in medicines 
used, which may outweigh the benefits of treatment (King, 2013). 
To date, no investigation has been done on the costs of footrot by different 
management strategies. In this analysis we use further data from the 162 farmers who 
responded to the 2006 questionnaire (Wassink et al., 2010a) and the University of Reading 
cost calculator model for footrot,2 to estimate treatment costs and production losses. The 
model’s calculations are based on the best available evidence and expert opinion on costs and 
economic losses.2 The overall costs per ewe per year (PEPY) by flock were used to 
investigate the relative cost-benefit of different methods for managing lameness. 
                                                 
2 See: Farm Health Planning models: Calculating the costs and benefits of controlling disease, 
http://www.fhpmodels.reading.ac.uk/index.htm (accessed 22/07/2013) 
Materials and Methods 
Questionnaire design and administration 
A questionnaire, described previously (Wassink et al., 2010a), was sent in 2006 to all 
265 farmers who participated in Kaler and Green (2008) and indicated willingness to 
participate in further research. Data were entered into Excel 2003 and analysed in Minitab 17 
(Minitab Ltd, UK) and Stata 13.0 (StataCorp, USA). 
Management of lameness 
Farmers were provided with a semi-closed list of whole-flock and individual methods 
for managing and treating lameness (Tables 2 and 3) and asked their frequency of doing each 
procedure and how long they took on each occasion.  
Farmer satisfaction with their management of lameness 
Farmers were asked how satisfied they were with their overall management of 
lameness on a 5-point Likert scale of ‘very satisfied’, ‘satisfied’, ‘neither satisfied nor 
dissatisfied’, ‘unsatisfied’, ‘very unsatisfied’, with an option of ‘don’t know’; and whether 
the methods they used to manage lameness made the best use of their time and money on a 3-
point scale of ‘yes’, ‘to some extent’, ‘no’. Kruskal-Wallis tests were used to investigate 
associations between time spent managing lameness, farmer satisfaction (overall, with use of 
time, with use of money) and prevalence of lameness. Box plots were visually assessed to 
establish that the distribution of the data met the assumptions of this test. 
Production and treatment costs by farmer satisfaction, prevalence of lameness and 
management of lameness 
The Farm Health Planning footrot calculator developed by Reading University2 was 
used to calculate treatment and production costs of lameness PEPY. Forty-six of 162 flocks 
were excluded because of missing data. 
The following data for each flock were put into the calculator: flock size, prevalence 
of lame ewes, time taken to treat individual sheep, and the frequency and time taken to 
vaccinate, foot trim and footbath the entire flock. The recovery rate for interventions was set 
at 50% for flock footbathing and isolation of lame sheep2; 20% for therapeutic foot trimming 
and 98% for individual clinical treatment (Kaler et al., 2010a).  All other values involved in 
the calculations were left as the program default values; based on studies by Green et al. 
(2007), Wassink et al. (2003), Wassink et al. (2010b) and expert opinion2 where there was no 
scientific evidence available (Table 1). "Prompt individual treatment" was defined as 
treatment within one week of observing a lame sheep and this option on the calculator was 
selected where appropriate. Farmer time was costed at the 2010 Craft grade rate3 (£8.15). All 
cost variables in the model from 2011 were similar in 2016; drug prices vary considerably but 
the median is similar to 2011,4 a cull ewe value was £79.48 on 09/04/20165 versus £80.00 in 
2011 (Table 1), finished lamb values fluctuated around £60/head 2015-2016 and store lamb 
prices5 and NFSCo charges (H. Davies, personal communication) were also similar to 2011, 
therefore these were not adjusted. 
Flocks were categorised by period prevalence of lameness into <5%, 5-<10%, ≥10% 
as in Wassink et al. (2010a), and costs of treatment and production losses attributed to footrot 
PEPY were calculated for each group. Overall cost, treatment cost and production cost of 
footrot PEPY and prevalence of lameness were calculated by farmer satisfaction with use of 
money and compared using Kruskal-Wallis tests. 
                                                 
3 See: Agricultural wages order 2010, 
http://webarchive.nationalarchives.gov.uk/20130822084033/http://archive.defra.gov.uk/foodfarm/far
mmanage/working/agwages/documents/awo10.pdf (accessed 22/07/2013) 
4 See: Farmacy, http://www.farmacy.co.uk/ (accessed 26/04/2016); VioVet, http://www.viovet.co.uk/ 
(accessed 26/04/2016); Wern Vets http://www.wernvets.co.uk/ (accessed 26/04/2016) 
5 See: AHDB Beef & Lamb Market Reports, http://beefandlamb.ahdb.org.uk/markets/auction-market-
reports/weekly-gb-regional-averages/ (accessed 26/04/2016) 
A linear regression model (Dohoo et al., 2003) was used to estimate univariable and 
multivariable associations between the log overall cost of lameness PEPY from the Reading 
calculator and management practices. Explanatory variables tested were isolating, moving, 
catching and foot trimming individual lame sheep; treatment with parenteral or topical 
antibiotics, a painkiller or vaccination; and for the whole flock, footbathing, foot trimming, 
vaccination and moving the flock. 
A manual forward selection process (Dohoo et al., 2003) was used to test variables in 
a multivariable model and explanatory variables were considered significant when 95% 
confidence intervals did not include unity (Wald’s test for significance) and were retained in 
the model (Cox and Wermuth, 1996). Where multi-collinearity was present, the most 
biologically plausible variable was included in the multivariable model. Model fit was 
assessed using plots of the standardised residuals against the predicted values. 
Results 
Response rate and descriptive statistics 
There were 162/265 (61%) useable responses; not all farmers answered all questions. 
Median flock size was 275 ewes (inter-quartile range [IQR] 120-550) and median period 
prevalence of lameness was 5% (IQR 4-10, range 0-60). Prevalence of lameness did not vary 
significantly by flock size (P=0.3). 
Management of lameness 
The most common whole-flock management procedures were footbathing, routine 
foot trimming and moving sheep for treatment (Table 2). Foot trimming was the most time 
consuming activity (Table 2). The most common treatments for individual lame sheep were 
therapeutic foot trimming, topical antibiotic spray and antibiotic injection (Table 3). 
Frequency of flock inspections for lameness 
As the frequency at which farmers checked their sheep for lameness decreased, the 
time spent inspecting each ewe per occasion increased, but the overall amount of time spent 
checking ewes decreased (Table 4). Prevalence of lameness was not significantly associated 
with time spent checking each ewe (P=0.7), time spent checking the flock (P=0.4) or the 
frequency of checks (P=0.1), although farmers who checked sheep once each week had a 
median of 8% lameness compared to 5% in all other groups. 
Farmer satisfaction with time spent managing lameness and actual time spent per ewe 
One hundred and sixteen farmers answered questions on satisfaction with 
management of lameness. Seventy-five of 116 (64%) farmers were ‘satisfied’ or ‘very 
satisfied’ with overall management of lameness in ewes and 53/116 (46%) farmers 
considered that their methods for managing lameness made best use of their time (Table 5). 
The median prevalence of lameness was lower when farmers were satisfied with use of time 
managing lameness compared with farmers who were satisfied ‘to some extent’ or ‘not 
satisfied’. Satisfied farmers spent significantly less time managing lameness than farmers 
who were not satisfied (Table 5). 
Farmer satisfaction with money spent managing lameness and actual cost per ewe 
Forty-eight of 116 (41%) farmers thought that their methods for managing lameness 
made best use of their money and 48/116 (41%) did ‘to some extent’. Overall costs 
significantly increased with lameness prevalence; treatment costs increased as prevalence of 
lameness increased from <5% to ≥10% but this was not statistically significant (Table 6). 
Farmers satisfied with use of money spent on lameness had significantly lower treatment and 
overall costs than farmers dissatisfied with use of money (Table 7). 
Management strategies associated with the cost of lameness 
In the multivariable model (Table 8) parenteral antibiotic treatment of individual lame 
sheep was associated with a £0.79 (95% CI: £0.18-1.29) reduction in overall cost of lameness 
PEPY. Routine footbathing (£0.90, 95% CI: £0.08-1.90), routine foot trimming (£2.96, 95% 
CI: £1.77-4.43%) and vaccination (£1.19, 95% CI: £0.05-2.69) were associated with a 
significant increase in cost PEPY. Parenteral and topical antibiotic treatments and foot 
trimming individual lame sheep were positively correlated with each other, and with catching 
lame sheep for treatment (Supplementary Table 1). Vaccination of individual lame sheep was 
strongly positively correlated with vaccination of the whole flock. The model fit was good 
(Fig. 1). 
Discussion 
The key findings are that overall costs of lameness PEPY were significantly lower in 
flocks in the study that were following the evidence-based best managements for minimising 
the prevalence of lameness in sheep; prompt treatment of ewes with parenteral and topical 
antibiotics (Kaler et al., 2010a; Wassink et al., 2010b) and avoiding whole-flock foot 
trimming and routine footbathing (Wassink et al., 2003; Kaler and Green, 2009; Winter et al., 
2015). 
There was a net financial benefit (£0.79 PEPY) of managing lameness by treating 
individual lame ewes with parenteral antibiotics compared with not using this treatment, 
despite farmers’ anecdotal concerns (King, 2013). Prompt parenteral antibiotic treatment is 
therefore not only the best method for reducing the prevalence of lameness (Wassink et al., 
2010b), it was also the most cost-effective strategy for management of lameness across the 
116 flocks in this analysis. 
Routine foot trimming and footbathing cost farmers an additional £3.86 PEPY, with 
no reduction in prevalence of lameness. Whilst this averaged cost must be interpreted with 
caution because of the variability in costs between farms, it highlights that significant savings 
could be made if farmers stopped using ineffective whole-flock managements. The farmers in 
this study would save £2.96 PEPY if they stopped routine foot trimming (Wassink et al., 
2003; Kaler and Green, 2009; Winter et al., 2015) and £0.90 PEPY if they stopped much 
routine footbathing (Wassink et al., 2003; Kaler and Green, 2009; Winter et al., 2015) and 
only footbathed to prevent or treat ID, which is associated with a lower prevalence of 
lameness (Kaler and Green, 2009; King, 2013; Winter et al., 2015).  
Most farmers in this study using therapeutic antibiotic treatment were also foot 
trimming. Kaler et al. (2010a) reported that therapeutic foot trimming in conjunction with 
antibiotic treatment halves the rate of recovery. Foot trimming also leads to repeated episodes 
of footrot, and poor foot conformation (Kaler et al., 2010b). Farmers in the current study who 
did not use therapeutic foot trimming saved 4 minutes per ewe treated (Table 3), and 
therefore saved money. Therefore, if all the farmers stopped therapeutic foot trimming they 
would have saved money and reduced the prevalence of lameness in their flock. 
There was no association between vaccination and the prevalence of lameness in these 
flocks (Wassink et al., 2010a); consequently, because of costs to purchase and administer 
vaccines it was a cost in these flocks. The 13% of farmers who vaccinated their sheep 
appeared aware of this, and did not consider vaccination effective or made best use of money 
(Wassink et al., 2010a). In a recent study vaccination against footrot was associated with an 
average 20% reduction in prevalence of lameness (Winter et al., 2015), therefore it may be of 
use in some flocks, for example those with high prevalence of lameness. 
The higher overall costs of lameness in flocks with ≥10% prevalence, compared with 
<5% lameness, were mainly attributable to increased production losses, although inefficient 
treatment may have contributed to costs on some farms as discussed previously. Production 
losses arise when ewes are lame for >6 days, and are therefore lowest in flocks where ewes 
are treated promptly (Wassink et al., 2010b). 
This is the largest study of the economics of treatment of lameness to date. Despite 
this, 116 is a relatively small sample and therefore there is limited power to the study and a 
risk of failing to detect true differences. There was a non-significant dose-response effect 
with treatment costs PEPY increasing as prevalence of lameness increased (Table 6). This 
may have been significant with a larger sample size than the 116 farms in this study; 
however, there was wide variation in treatment costs across all farms. This is probably a true 
reflection of the variability in treatment costs because we would expect the large variability to 
remain with a larger sample size. This is because some flocks with low prevalence of 
lameness have few sheep that become lame and therefore incur minimal treatment costs, 
whilst other flocks with low prevalence of lameness will be controlling lameness by treating 
sheep promptly and therefore will incur higher costs. Similarly, flocks with high prevalence 
of lameness will have low treatment costs if farmers rarely treat lame sheep, and others will 
have high costs if they waste time and money using ineffective practices such as routine foot 
trimming. The limited sample size may also have contributed to the non-significance 
observed for some cost-benefit estimates in Table 8 (treatment of individual lame sheep with 
topical antibiotics, painkillers or therapeutic foot trimming; catching, moving or isolating 
lame sheep, or moving the whole flock); potentially increasing the chance that estimates of 
the real effect would not be statistically significant. 
In the current study, the net benefit of prompt parenteral antibiotic treatment of lame 
ewes was £0.79 per ewe across 116 flocks with IQR 4-10% lameness, whilst in Wassink et 
al., (2010b) the benefit was £6 per ewe in a within-flock comparison of a group with 2% 
versus a group with 6-8% lameness. The current study is far less controlled than the within-
flock comparison of Wassink et al. (2010b) which creates greater random error; however, it 
does compare 116 farms. The smaller difference in overall cost-benefit of using parenteral 
antibiotics in the current study might be attributable to a higher prevalence of lameness in the 
lowest category of lameness (up to 5%), and so greater treatment costs and less difference 
between the prevalence of lameness in the flocks compared. In addition, most farmers in the 
current study practised therapeutic foot trimming, which delays recovery (Kaler et al., 2010a) 
and routine foot trimming and footbathing, which cost time and might increase lameness. In 
the footrot calculator these procedures are credited as benefitting sheep; this is clearly not the 
case (Wassink et al., 2003, 2004; Kaler and Green, 2008; Winter et al., 2015) and therefore 
the cost-benefit of these interventions will have been overestimated in the current study. 
Routine and therapeutic foot trimming and footbathing were not done during the Wassink et 
al. (2010b) study, and so less time, and therefore money, was spent on these unnecessary 
activities. Wassink et al. (2010) also classed treatment as “prompt” at <3 days, versus <1 
week in the current study. The financial benefit of parenteral antibiotic treatment is probably 
higher if treatment is given sooner because of the reduction in onward transmission of 
disease; unfortunately, we did not have the data to investigate this. 
The data for the current study were collected in 2007 and it is unlikely that the time 
taken for a management practice has changed since then. Medicines and management costs 
are still at similar prices to 2011, when the cost calculator was developed. Finished and cull 
ewe prices fluctuate widely but 2016 prices are very similar to 2011 e.g. £79.48 versus 
£80.00 for a cull ewe. Farmer time is notoriously difficult to cost but the cost used was that 
determined by the 2010 Craft grade rate. As a general rule, if the market price of lamb 
increases above £60/head the cost calculator estimate for production losses from incorrect 
treatment increase. 
This study is the largest investigation of costs and benefits for management of 
lameness in English flocks to date. Previous analyses were based on a single-flock (Wassink 
et al., 2010b) and a simulation model (Nieuwhof and Bishop, 2005). One question that arises 
is whether the results are generalizable to all English lowland flocks. The original selection of 
farmers came from a random selection of farmers in the AHDB Beef & Lamb Better Returns 
programme. This consists of 18,000 English sheep farmers and is the most comprehensive list 
of sheep farmers that can be accessed. This is the same list used for 50% of participants in the 
2013 questionnaire (Winter et al., 2015), the remaining 50% were sourced from a complete 
list of sheep farmers held by DEFRA. There was no measurable difference in sheep farmers 
sourced from DEFRA or AHDB by prevalence of lameness, response rate or managements 
investigated (unpublished data). When considering the respondents, the response rate was 
61%, similar to other studies involving second questionnaires to compliant farmers (Wassink 
et al., 2003; Kaler and Green, 2008). The median prevalence of lameness was 5%, similar to 
estimates in 2004 and 2011 (Kaler and Green, 2008; King, 2013). The flock size in this study 
(median 275, IQR 120-550) was similar to the average flock size in 2006 of 327 ewes (Rural 
Business Research, 2007) and there was considerable overlap with flock size IQRs from other 
random studies (Kaler and Green, 2008; King, 2013; Winter et al., 2015). Management 
practices i.e. using “best practice” (O'Kane et al., 2016) of prompt parenteral and topical 
antibiotic are also similar to those in a recent study of a random sample of farmers (Winter et 
al., 2015). The number of farmers using footbathing as treatment for footrot has fallen to 36% 
since 2006 (Winter et al., 2015), possibly a result of promotion of alternative effective 
management practices. Therefore, as far as it is possible to ascertain, the farmers in the 
current study are largely similar to other farmers who have contributed to research on ovine 
lameness in England. It is not possible to know if the farmers in this study, or any of the other 
studies listed, are representative of all sheep flocks because those who do not reply to a 
questionnaire are unknown. However, over the past ten years the prevalence of lameness has 
halved (Winter et al., 2015) using results from these studies to inform farmers of the best 
management strategies. The main comparison in the current study is the relative difference in 
costs by different management strategies between flocks; this calculation does not require a 
population-based sample. Consequently, even if the flocks in the study are not representative 
of all sheep flocks, the estimated differences in costs by management strategy are expected to 
be similar for other lowland farms in England. 
Conclusions 
We conclude that for the farmers in the current study there was a net financial benefit 
of £0.79 PEPY from using prompt antibiotic treatment, predominantly because of lower 
production losses. If these farmers also stopped therapeutic foot trimming, the financial 
benefit would be higher. Routine foot trimming and footbathing, previously associated with 
higher prevalence of lameness, were associated with increased costs of lameness; £2.96 and 
£0.90 respectively. If these farmers stopped these practices they would save a further average 
of £3.86 PEPY. If the costs in the current study are similar for other sheep flocks in England, 
these results indicate that adopting best practice to treat and control footrot would benefit the 
health of sheep and the economics of sheep farming. 
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Tables and Figures 
Table 1 
Assumptions used in the University of Reading footrot calculator. 
Flock and footrot details Assumed  value 
Expected lambing percentage (at scanning) 150% 
Percentage lambs sold as finished 25% 
Percentage of ewes with footrot culled 3% 
Average finished lamb value £60/head 
Average store lamb value £40/head 
Average cull ewe value £80/head 
National Fallen Stock Company (NFSCo) charges £20/head 
  
Treatment Cost per ewe 
Individual clinical treatment (parenteral antibiotic) £1.30 
Isolation of clinical case £1.00 
Chemical cost of flock footbathing £0.10 
Vaccination product cost (per dose, per ewe) £0.80 
Cost of routine flock foot trim £1.30 
  
Response to treatment Response rate 
Prompt individual clinical treatment (parenteral antibiotic) 98% 
Isolation of clinical case 50% 
Flock footbathing 50% 
Routine foot trimming of all sheep 20% 
  
Effects of disease on ewes Percentage reduction 
Dry ewe conception rate 15% 
Dry ewe condition 15% 
Dry ewe survival 2% 
Pregnant ewe condition 15% 
Pregnant ewe survival 5% 
Lactating ewe condition 15% 
Lactating ewe survival 5% 
Lambing percentage 15% 
Lamb survival 12% 
Number of finished lambs 15% 
  
Table 2 
Whole-flock management practices used by 162 English farmers in 2006. 
Flock 
management 
Minutes per ewe Frequency of 
management, per year 
Hours, per 100 




Median IQR a Median IQR Median IQR 
Routine foot 
trim 
4.2 2.5-7.5 2.0 1.0-2.0 11.2 5.7-24.7 80 (49) 
Footbath 1.0 0.6-1.8 4.0 2.0-9.0 6.2 3.3-17.9 92 (57) 
Vaccine 1.1 0.6-2.0 1.0 1.0-1.0 1.8 1.0-4.7 21 (13) 
Move to 
treatment area 
0.5 0.2-1.3 3.5 2.0-9.5 3.4 1.0-8.1 71 (44) 
a IQR = interquartile range   
Table 3 
Number and percentage of 162 English Sheep farmers using different methods to treat footrot 
in individual lame ewes, and the median time per activity, in 2006. 
Management practice Minutes per activity, per ewe Number (%) farmers 
using this management 
Median IQR a 
Move to treatment area 10 2-15 51 (31) 
Isolate ewe 5 2-10 5 (3) 
Therapeutic foot trim 4 2-5 136 (84) 
Catch ewe 2 1-5 128 (79) 
Footbath 1 1-5 89 (55) 
Vaccinate 1 1-3 20 (12) 
Antibiotic spray 1 1-2 131 (81) 
Antibiotic injection 1 1-2 101 (62) 
a IQR = interquartile range   
Table 4 





Minutes spent per ewe, per 
inspection 
Minutes spent per ewe, per 
week 
Median IQR a Median IQR 
Everyday 87 (53.7) 0.28 0.15-0.50 1.93 1.05-3.50 
Twice a week 19 (11.7) 0.33 0.18-1.17 0.66 0.35-1.50 
Once a week 26 (16.0) 0.48 0.31-1.38 0.48 0.31-1.38 
< Once a week 27 (16.7) 0.29 0.00-0.60 0.09 0.00-0.18 
Kruskal Wallis test  P=0.02 P<0.01 
a IQR = interquartile range  
Table 5 
The median management time per ewe per year (PEPY) and prevalence of lameness for 
flocks grouped by farmer ratings of overall satisfaction and satisfaction with use of time. 
a IQR = interquartile range   




Prevalence of lameness 
Median IQR a Median IQR 
Overall satisfaction      
Very Satisfied 11 (9) 2.36 0.42-3.91 3.0 2.0-10.0 
Satisfied 64 (55) 1.84 0.97-3.96 5.0 3.0-7.75 
Neither 25 (22) 1.90 0.94-5.22 10.0 5.0-10.0 
Unsatisfied / Very Unsatisfied 16 (14) 1.20 0.58-1.81 8.5 5.0-15.0 
Kruskal-Wallis test  P=0.35 P=0.01 
Satisfaction with use of time    
Satisfied 53 (46) 1.46 0.72-3.18 5.0 3.0-10.0 
Satisfied to some extent / 
Unsatisfied 
59 (51) 1.90 1.02-4.59 7.0 5.0-10.0 
Kruskal-Wallis test  P=0.04 P<0.01 
Table 6 
Overall costs, treatment costs, and production losses per ewe per year (PEPY) by prevalence 





Overall cost PEPY (£) Treatment cost PEPY 
(£) 
Production losses PEPY 
year (£) 
Median IQR a Median IQR Median IQR 
< 5 34 (29.3) 3.90 2.15-5.75 2.67 1.22-4.86 0.80 0.56-1.05 
5 - < 10 44 (37.9) 5.15 2.85-7.75 3.47 1.08-6.41 1.51 1.45-1.61 
≥ 10 38 (32.8) 6.35 4.95-8.38 3.68 2.04-5.30 2.40 2.23-2.87 
Kruskal-Wallis test   P<0.01 P=0.43 P<0.01 
a IQR = interquartile range  
Table 7 
Prevalence of lameness, overall and treatment costs of footrot per ewe per year (PEPY) by 
farmer satisfaction with use of money 
Farmer satisfaction 
with use of money 
n % Lame Overall cost  PEPY (£) Treatment cost PEPY (£) 
Median IQR a Median IQR Median IQR 
All farmers 116 5.0 4.0-10.0 5.45 3.30-7.60 3.47 1.41-5.43 
Satisfied 48 5.0 3.0-10.0 5.00 2.70-7.10 2.94 0.84-5.03 
Satisfied to some 
extent 
48 6.0 4.5-10.0 4.95 3.33-6.70 2.95 1.29-4.59 
Unsatisfied 6 6.0 4.25-15.0 7.60 5.48-8.78 5.50 3.00-7.83 
Don't know 14 8.0 4.5-12.8 6.60 4.70-12.63 4.07 3.40-8.46 
Kruskal-Wallis test  P=0.17 P=0.02 P=0.03 
a IQR = interquartile range 
  
Table 8 1 
Univariable and multivariable linear regression model of management practices associated with changes in overall cost of lameness per ewe per 2 
year (PEPY) in 116 English sheep flocks. 3 







95% CI a P value 
Change 
in cost 
95% CI P value 
Individual treatments 
           
Parenteral antibiotic N b 39 33.6% 
        
 
Y c 77 66.4% -£0.82 -£1.41 -£0.06 0.039 -£0.79 -£1.29 -£0.18 0.015 
Topical antibiotic N 15 12.9% 
        
 
Y 101 87.1% -£0.86 -£1.64 +£0.26 0.123 
    
Foot trim N 14 12.1% 
        
 
Y 102 87.9% -£0.97 -£1.74 +£0.14 0.082 
    
Isolate N 95 81.9% 
        
 
Y 21 18.1% -£0.04 -£0.96 +£1.23 0.947 
    
Move N 80 69.0% 
        
 
Y 36 31.0% +£0.54 -£0.38 +£1.73 0.277 
    
Catch N 19 16.4% 
        
 
Y 97 83.6% -£0.19 -£1.10 +£1.07 0.734 
    
Painkiller N 111 95.7% 
        
 
Y 5 4.3% -£0.24 -£1.69 +£2.39 0.817 
    
Vaccination N 104 89.7% 
        
 
Y 12 10.3% +£2.42 +£0.54 +£5.19 0.008 
    
Flock management strategies 
         
Footbath N 46 39.7% 
        
 
Y 70 60.3% +£1.70 +£0.61 +£3.07 0.001 +£0.90 +£0.08 +£1.90 0.031 
Foot trim N 46 39.7% 
        
 
Y 70 60.3% +£3.68 +£2.33 +£5.33 <0.001 +£2.96 +£1.77 +£4.43 <0.001 
Move N 59 50.9% 
        
 
Y 57 49.1% +£0.64 -£0.24 +£1.75 0.172 
    
Vaccination N 98 84.5% 
        
 
Y 18 15.5% +£2.38 +£0.78 +£4.59 0.002 +£1.19 +£0.05 +£2.69 0.041 
Lameness 
           
For each percentage increase 
 
+£0.14 +£0.08 +£0.20 <0.001 
    
The intercept of the model was £3.47 (95% CI: £2.76-4.35, P<0.001). Associations significant at p≤0.05 (Wald’s statistic) are shown in bold. a CI: confidence interval. b N: 4 
no. c Y: yes.  5 
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Figure 1 8 
Plot of the predicted values against the standardised residuals, for the linear regression model 9 
of management practices associated with log cost of lameness 10 
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